Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy
RA Rizza, JE Gerich, MW Haymond, RE Westland, LD Hall, AH Clemens, and FJ Service
We compared the ability of closed-loop intravenous insulin infusion (i.e., an artificial "pancreas"), open-loop continuous subcutaneous insulin infusion, and intensified conventional insulin therapy (preprandial injections of regular insulin, with injection of long-acting zinc-suspension insulin before breakfast) to bring the hyperglycemia of insulin-dependent diabetic subjects to a level comparable to that of normal, nondiabetic subjects. The mean circadian levels of plasma glucose, mean amplitude of glycemic excursions, and M values (defined in Methods) did not significantly differ among the three regimens. Although these levels in the diabetic subjects approximated those in the normal subjects, the levels of plasma insulin, mean amplitude of glycemic excursions, and M values were significantly higher than those in normal subjects (P < 0.01). Therefore, at least on a short-term basis, all three regimens can produce comparable, nearly normal levels of blood sugar in such patients; moreover, closed-loop devices can be used to determine insulin requirements for conventional therapy.
This article has been cited by other articles:
Vella, A., Shah, P., Basu, A., Rizza, R. A.
(2008). Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes. Diabetes Care
31: 2230-2231
[Full Text]
Kudva, Y. C., Basu, A., Jenkins, G. D., Pons, G. M., Quandt, L. L., Gebel, J. A., Vogelsang, D. A., Smith, S. A., Rizza, R. A., Isley, W. L.
(2005). Randomized Controlled Clinical Trial of Glargine Versus Ultralente Insulin in the Treatment of Type 1 Diabetes. Diabetes Care
28: 10-14
[Abstract][Full Text]
Levetan, C., Want, L. L., Weyer, C., Strobel, S. A., Crean, J., Wang, Y., Maggs, D. G., Kolterman, O. G., Chandran, M., Mudaliar, S. R., Henry, R. R.
(2003). Impact of Pramlintide on Glucose Fluctuations and Postprandial Glucose, Glucagon, and Triglyceride Excursions Among Patients With Type 1 Diabetes Intensively Treated With Insulin Pumps. Diabetes Care
26: 1-8
[Abstract][Full Text]
Fruehwald-Schultes, B., Kern, W., Bong, W., Wellhoener, P., Kerner, W., Born, J., Fehm, H. L., Peters, A.
(1999). Supraphysiological Hyperinsulinemia Acutely Increases Hypothalamic-Pituitary-Adrenal Secretory Activity in Humans. J. Clin. Endocrinol. Metab.
84: 3041-3046
[Abstract][Full Text]
Van Cauter, E., Polonsky, K. S., Scheen, A. J.
(1997). Roles of Circadian Rhythmicity and Sleep in Human Glucose Regulation. Endocr. Rev.
18: 716-738
[Abstract][Full Text]
Tuominen, J. A., Ebeling, P., Stenman, U.-H., Heiman, M. L., Stephens, T. W., Koivisto, V. A.
(1997). Leptin Synthesis Is Resistant to Acute Effects of Insulin in Insulin-Dependent Diabetes Mellitus Patients. J. Clin. Endocrinol. Metab.
82: 381-382
[Abstract][Full Text]
Skyler, J. S.
(1989). Intensive Insulin Therapy: A Personal and Historical Perspective. The Diabetes Educator
15: 33-39
Young, A., Herf, S.
(1984). Biostator Glucose Controller: A Building Block of the Future. The Diabetes Educator
10: 11-13
